Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Ex-vivo and in vivo sirna delivery to activated t cells as novel anti-inflammatory asthma therapy
- In: DDA SYMPOSIUM: PULMONARY DRUG DELIVERY on Wednesday, 16 April 2014, 13:00-14:30
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: MERKEL, Olivia (Wayne State University, Pharmaceutical Sciences, Detroit, United States of America)
- Co-author(s): Kim, Na Hyung (Wayne State University, Detroit, United States of America)
Nadithe, Venkatareddy (Wayne State University, Detroit, United States of America)
Thakur, Archana (Wayne State University, Detroit, United States of America)
Lum, Lawrence (Wayne State University, Detroit, United States of America)
Bassett, David J.P. (Wayne State University, Detroit, United States of America)
Xie, Yuran (Wayne State University, Detroit, United States of America) - Abstract:
Local, targeted, cell-specific RNA interference (RNAi)-based therapies could improve patients' ability to control asthma. Allergen-induced airway dysfunction was shown to be prevented by downregulating the secretion of Th2 cytokines. However, T cells are hard to transfect cells and not easily accessible for RNAi-based therapies. We recently..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023